Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.

Item
http://www.wikidata.org/entity/Q45107227
Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case reportAnagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologistsPharmacological management of essential thrombocythemia.Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.Anagrelide for control of thrombocytosis due to myeloproliferative disorders.Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS studyAnagrelide: 20 years later.Role of platelet counts in the management of essential thrombocythemia: experience with anagrelide.Advances and challenges in the management of essential thrombocythemia.A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
P2860

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.

Item
http://www.wikidata.org/entity/Q45107227
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@en
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@nl
type
label
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@en
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@nl
prefLabel
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@en
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2257.2004.00637.X
P433
P478
P50
P577
P698